Health and Healthcare

More Pain for Questcor

Questcor Pharmaceuticals Inc. (NASDAQ: QCOR) is a situation that has gone from bad to worse. Last week there was a huge drop on the news Aetna Inc. (NYSE: AET) was altering its reimbursement coverage, but now comes new news that it is being investigated by the U.S. government over its promotional practices.

Its SEC Filing noted:

On September 21, 2012, Questcor Pharmaceuticals, Inc. (the “Company”) became aware of a U.S. government investigation involving the Company’s promotional practices. The Company intends to cooperate with the government in its investigation. Company representatives will not be able to provide any additional information on this matter, other than through potential public Regulation FD-compliant disclosures.

Last week we saw shares literally fall from just over $50.00 all the way down to $26.35 in one day. Shares closed at $30.13 by the end of the week as some investors and traders were hoping that the sell-off had dropped shares too far and too fast. That was then. Shares are trading down another 17.5% at $24.75 in early Monday trading.

The only good news is that the drop so far has not gone under the low last week of $22.26.

JON C. OGG

Is Your Money Earning the Best Possible Rate? (Sponsor)

Let’s face it: If your money is just sitting in a checking account, you’re losing value every single day. With most checking accounts offering little to no interest, the cash you worked so hard to save is gradually being eroded by inflation.

However, by moving that money into a high-yield savings account, you can put your cash to work, growing steadily with little to no effort on your part. In just a few clicks, you can set up a high-yield savings account and start earning interest immediately.

There are plenty of reputable banks and online platforms that offer competitive rates, and many of them come with zero fees and no minimum balance requirements. Click here to see if you’re earning the best possible rate on your money!

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.